CXCR2 and hepatocellular carcinoma: Evidently, the overexpression of CXCR2 in GPC3 CAR-T cells enhanced the in vivo trafficking, accumulation, and anti-tumor efficacy of these cells in hepatocellular carcinoma xenograft models that express high levels of CXCR2 ligands [108].